Eingabe löschen

Kopfbereich

Schnellnavigation

Hauptnavigation

TEDD Annual Meeting 2019: Cell Sources and Stem Cell Generation for Drug Development

24. Oktober 2019

TEDD Annual Meeting brings together experts from diverse fields with a shared interest in advanced 3D models. Join us for this meeting to celebrate another fruitful collaboration year with the new perspectives ahead.

Primary and stem cells are becoming important sources for the generation of organotypic tissue models used in many biopharmaceutical applications, regenerative medicine, disease modelling and drug discovery. They promise to revolutionize the drug discovery process at all stages, from target identification through to toxicology studies. 

While primary cells by nature represent the native tissue most accurately, they usually have limited capacity to divide and thus need to be freshly isolated for each assay limiting their application. In contrast the ability of stem cells to generate physiologically relevant cells in limitless supply makes them an attractive alternative to currently used recombinant cell lines or primary cells. Emerging technologies involve the production of organoids from human pluripotent stem cells (hPSCs) and the use of organ-on-a-chip devices. These approaches are showing great promise for developing a more reliable, rapid and cost-effective process when compared with the current use of animal models. 

The current challenges include routinely directing stem cell differentiation to reproducibly and cost-effectively generate pure specific lineages.  

During TEDD Annual Meeting, we will discuss how stem cells have already been used in the drug discovery process and how novel technologies can be applied to attain widespread adoption of stem cell technology by the pharmaceutical and biotech industry.  

PROGRAM (PDF 1,8 MB)

REGISTRATION

  • Opens 5. August 2019
  • Deadline 7. October 2019

SPEAKERS

  • Wing Chang, StemCell Technologies, United Kingdom
  • Bruno Filipi, ZHAW, Switzerland
  • Zhongze Gu, School of Biological Science and Medical Engineering (Nanijing), Institute of Biomedical Devices (Suzhou), SEU Southeast University, China 
  • Christian Hinderling, ZHAW, Switzerland
  • Marisa Jaconi, Dept. Pathology and Immunology, Faculty of Medicine, Geneva University, Switzerland
  • Cornelia Kasper, BOKU University of Natural Resources and Life Sciences, Austria
  • Kenneth Lee, Chinese University of Hong Kong, Hong Kong
  • Michael Raghunath, ZHAW, Switzerland
  • Markus Rimann, ZHAW, Switzerland
  • Phil Stephens, Cardiff University, United Kingdom
  • Parto Toofan, REPROCELL Europe, United Kingdom

EXHIBITION

Companies will exhibit during famous two-hours long lunch break at the Greenhouse, where all participants are present. 

  • Ariadne.ai
  • C-CIT
  • Celvivo
  • Corning
  • Dispendix
  • Ectica Technologies (comes for Labforce)
  • Kugelmeiers
  • Maco Pharma
  • PELOBiotech
  • Regen Lab
  • regenHu
  • Rigenerand
  • Tecan
  • UPM
  • Zeiss

 COSTS

  • TEDD Partner (Two first participants) No entrance fee
  • TEDD Partner (Third and next participant) 50% off standard fee CHF 80.-
  • Standard fee CHF 160.-
  • Students CHF 80.-

 

VENUE

Zurich University of Applied Science (ZHAW), Campus Grüental 8820 Wädenswil (Switzerland)

  • Talks: Aula GA 203
  • Lunch and Exhibition: Kalthaus GC 181

TEDD Annual Meeting 2018 - Impressions

Datum

Von: 24. Oktober 2019
Bis: 24. Oktober 2019

Veranstalter

ZHAW Institut für Chemie und Biotechnologie
Grüentalstrasse 14
8820 Wädenswil

+41 58 934 50 00
info.icbt@zhaw.ch

ZHAW Institut für Chemie und Biotechnologie